Why does the COVID-19 virus make some people sicker than others? For years, scientists have looked to a critical piece of ...

Motzer and colleagues present updated results from a multicenter, phase III trial of sunitinib versus interferon-α as first-line treatment for patients with metastatic renal-cell carcinoma.

Interferon beta is commonly used in the treatment of multiple sclerosis. Previous clinical trials conducted by Synairgen have shown that it can stimulate an immune response and that patients with ...